North America

MGH and Siemens Healthineers Partner to Launch Therapy Command Center

Strategic collaboration aims to enhance real-time clinical decision-making and streamline cancer care through centralized, AI-driven support....

Femasys Secures European Approval for FemBloc®

First-Ever Non-Surgical Permanent Birth Control System Gains CE Mark, Paving the Way for a New Era in Reproductive Health...

Stryker Receives FDA Clearance for InCompass™ Total Ankle System

Next-Generation Ankle Replacement Platform Designed to Improve Surgical Precision and Patient Outcomes in Orthopaedic Care...

New GLP-1 Therapies Redefine Weight Loss Standards

Emerging Treatments Show Promise in Preserving Muscle Mass While Promoting Fat Reduction, Elevating the Quality of Metabolic Care...

Neuspera Medical Secures FDA Approval for First-of-Its-Kind iSNM System

Breakthrough Integrated Sacral Neuromodulation Device Approved to Treat Urinary Urge Incontinence with a Minimally Invasive, Patient-Centric Approach...

InspireMD Secures FDA Approval for CGuard® Prime Carotid Stent System

Next-Generation Stent Designed to Prevent Stroke by Combining Embolic Protection and Advanced Plaque Management in Carotid Artery Disease...

NanoVibronix’s ENvue Medical Signs Agreement with NY Medical Center for Enteral Navigation System Deployment

ENvue™ technology to support accurate, radiation-free placement of enteral feeding tubes, enhancing patient safety and clinical efficiency....

Insulet Expands Access with Omnipod® 5 iPhone App, Advancing Connected Diabetes Care

New app rollout enhances insulin automation and real-time glucose monitoring through seamless smartphone control....

Ancora Heart Inc. Reaches First Enrollment Milestone in CORCINCH-HF Heart Failure Pivotal Trial

Six-month safety and effectiveness data for the 250 randomized patients to support PMA submission to FDA; enrollment to continue to 400 ...

First Patient Treated with the Alteon® Short Tapered Wedge Total Hip Replacement

New construct represents a strategic expansion of the company's leading hip portfolio ...